A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production

A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production

Abstract Background A stereoisomer of inositol, scyllo-inositol (SI), has been regarded as a promising therapeutic agent for Alzheimer’s disease. However, this compound is relatively rare, whereas another stereoisomer of inositol, myo-inositol (MI) is abundant in nature. Bacillus subtilis 168 has th...

Full description

Bibliographic Details
Main Authors: Kosei Tanaka, Ayane Natsume, Shu Ishikawa, Shinji Takenaka, Ken-ichi Yoshida
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Microbial Cell Factories
Subjects:
Bacillus subtilis
scyllo-inositol
myo-inositol
Bioconversion
Alzheimer’s disease
Online Access:http://link.springer.com/article/10.1186/s12934-017-0682-0

Internet

http://link.springer.com/article/10.1186/s12934-017-0682-0

Similar Items